1.	Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: 06-14034, NCT00628784
2.	Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus. Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 16-00017, NCT00754468
3.	Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 82 Sponsor: Other Protocol IDs: Pro00002207, SPS 151596, NCT00578071
4.	Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 65 Sponsor: NCI Protocol IDs: RPCI-I-62705, I 62705, NCT00524121
5.	Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001) Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: BrUOG-E-215, NCT00522795
6.	Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: UMCC 2006.117, NCT00570531
7.	Endoscopic Therapy of Early Cancer in Barretts Esophagus Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 1399-05, CA111603-01A1, NCT00217087
8.	Randomized, Double Blind, Placebo-Controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NYU 05-409, NCT00821652
9.	Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 79 Sponsor: NCI Protocol IDs: NU-NWU08-11-01, NWU08-11-01, NCI-08-11-01, RPCI-I-121507, NCT01013831
10.	Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 99-0522, NCT00260559
11.	Chemoradiation-Induced Nausea and Emesis: Quality of Life Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2003-0529, NCT00394602
12.	IMRT Tomotherapy for Esophagus Cancer Phase: No phase specified Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 06-1070, NCT00593723
13.	The Effect of Ablation Therapy on Barrett's Esophagus Phase: No phase specified Type: Tissue collection/Repository, Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 258-04, NCT00587314
14.	Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations. Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Cell Saver 704.03, NCT00708513
15.	Comparison of Standard of Care or Treatment on Protocol Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: INST 0813, NCT01010334